Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
5.62
-0.04 (-0.71%)
At close: Jun 27, 2025, 3:59 PM
5.50
-2.14%
After-hours: Jun 27, 2025, 04:53 PM EDT
-0.71%
Bid 5.5
Market Cap 669.59M
Revenue (ttm) n/a
Net Income (ttm) -47.35M
EPS (ttm) -0.45
PE Ratio (ttm) -12.49
Forward PE -10.35
Analyst Buy
Ask 5.69
Volume 732,522
Avg. Volume (20D) 1,742,459
Open 5.64
Previous Close 5.66
Day's Range 5.51 - 5.71
52-Week Range 2.36 - 7.48
Beta 0.53

About TRVI

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRVI
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-5.85%
Trevi Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
3 weeks ago
-2.92%
TRVI stock has given up its prior gain. Trevi Therapeutics shares were trading higher after the company announced positive topline results from its Phase 2b CORAL trial of Haduvio.